US Patent 11744797 Rapamycin for the treatment of lymphangioleiomyomatosis
Patent 11744797 was granted and assigned to AI Therapeutics on September, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11744797 Rapamycin for the treatment of lymphangioleiomyomatosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.